What's New
Updated to incorporate all new information in Summaries of Product Characteristics to January 31st, 2013. Design improvements to enhance usability including hyperlinks on each drug screen to essential prescibing information for that drug (ie, indications, contraindications, cautions, drug interactions, and dosage). iPhone 5 and iOS 6 support. Includes newly licensed A2R blocker, azilsartan.
App Description
Up-to-date (to January 31, 2013), clear, concise, and consistently presented information on the safe use of A2R (angiotensin-II receptor) blockers licensed to treat hypertension, heart disease, and diabetic kidney disease to Avoid Adverse Effects in Adults. The screens have been specially edited and designed for the iPhone and iPad and you can add your favourites to Quick Find. The interface is easy and intuitive to navigate, colour-coded, searchable, zoomable, viewable in portrait and landscape, with useful hyperlinks throughout. Compiled and edited by highly experienced medical editor, UK-registered Dr Lindy van den Berghe, BMedSci, BM, BS. All information has been checked against the Summaries of Product Characteristics (SPCs) provided for each drug by the manufacturer. Regular free updates incorporating any new information in updated SPCs will be provided. See www.AAeARx.co.uk.
iPhone Screenshots
(click to enlarge)
iPad Screenshots
(click to enlarge)
App Changes
- June 16, 2014 Initial release
- July 11, 2016 Price increase: $0.99 -> $1.99
Other Apps From First Line Medical Communications
